CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$1.29 USD
-0.02 (-1.53%)
Updated Sep 16, 2024 04:00 PM ET
After-Market: $1.30 +0.01 (0.78%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.29 USD
-0.02 (-1.53%)
Updated Sep 16, 2024 04:00 PM ET
After-Market: $1.30 +0.01 (0.78%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Zacks News
Top Ranked Momentum Stocks to Buy for March 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 10th
3 Correction-Defying Bets to Buy as Markets Brave Coronavirus
by Manaswita Ghosh Dutta
Global markets lost $6 trillion in the week ended Feb 29 as coronavirus triggered sharp selloff. Here's how to play the dip.
The Zacks Analyst Blog Highlights: Co-Diagnostics, Regeneron Pharmaceuticals, Netflix, Norwegian Cruise Line and American Airlines
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Co-Diagnostics, Regeneron Pharmaceuticals, Netflix, Norwegian Cruise Line and American Airlines
4 Top Stocks to Win Big From the Coronavirus Pandemic (Revised)
by Tirthankar Chakraborty
Professional money managers are looking to buy stocks that act as a hedge against coronavirus threat, or those that simply benefits from the particular event.
Is Co-Diagnostics (CODX) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
Best & Worst Performing Stocks in Coronavirus Outbreak
by Tirthankar Chakraborty
Here're the big winners and losers since the coronavirus outbreak brought the U.S. bull market to a standstill.
The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Co-Diagnostics and Apple
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Co-Diagnostics and Apple
4 Top Stocks to Win Big From the Coronavirus Pandemic
by Tirthankar Chakraborty
Professional money managers are looking to buy stocks that act as a hedge against coronavirus threat, or those that simply benefits from the particular event.
The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Sprint, Stamps.com and Uniti
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Sprint, Stamps.com and Uniti
Top Ranked Momentum Stocks to Buy for March 2nd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 2nd.
Market in Correction: 5 Stocks Resist Virus Attack in February
by Sanghamitra Saha
Wall Street has entered into the correction territory after steep coronavirus-induced selloffs in February. But these stocks have gained massively.
The Wining Sector & Its Top Stocks in Virus-Infected January
by Sanghamitra Saha
January has turned out great for biotech stocks thanks to the coronavirus outbreak as well as a general upbeat trend.
Coronavirus Spooks Global Markets: Winners and Losers
by Zacks Equity Research
So far, 18 fatalities and more than 600 are affected by coronavirus in China and the virus is spreading across the boundary, spooking investors.